A phase diagram-based toolbox to assess the impact of freeze/thaw ramps on the phase behavior of proteins

  • 112 Accesses

  • 1 Citations


The influence of process parameters during freeze/thaw (FT) operations is essential for the preservation of the protein stability/activity during production and storage processes in the biopharmaceutical industry. Process parameters, such as FT ramps, the final storage time and temperature, affect the occurring FT stress onto the target protein in different ways. FT stress includes cold denaturation, freeze concentration, and ice crystal formation which can result in protein aggregation. To visualize the impact of variations in FT ramps, descriptors such as solubility, phase behavior and crystal morphology were evaluated. The phase diagram-based toolbox in combination with an HTS-compatible cryo-device allowed the identification of suitable ramping schemes during FT operations. It could be clearly shown that rapid operations are needed above the glass transition temperature of the target protein to circumvent precipitation during FT cycles. Finally, a stability index is introduced which allows ranking of the systems investigated.

Graphic abstract

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 199

This is the net price. Taxes to be calculated in checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6


  1. 1.

    Shamlou PA, Breen LH, Bell WV et al (2007) A new scaleable freeze–thaw technology for bulk protein solutions. Biotechnol Appl Biochem 46:13–26.

  2. 2.

    Ho K, Tchessalov S, Kantor A, Warne N (2008) Development of freeze and thaw processes for bulk biologics in disposable bags. Am Pharm Rev 11:1–6

  3. 3.

    Singh SK, Kolhe P, Mehta AP et al (2011) Frozen state storage instability of a monoclonal antibody: aggregation as a consequence of trehalose crystallization and protein unfolding. Pharm Res 28:873–885.

  4. 4.

    Wang W (2005) Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289:1–30.

  5. 5.

    Bhatnagar BS, Bogner RH, Pikal MJ (2007) Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol 12:505–523.

  6. 6.

    Kueltzo LA, Wang W, Randoplph TW, Carpenter JF (2008) Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze–thawing. J Pharm Sci 99:4215–4227.

  7. 7.

    Strambini GB, Gabellieri E (1996) Proteins in frozen solutions: evidence of ice-induced partial unfolding. Biophys J 70:971–976.

  8. 8.

    Hauptmann A, Podgoršek K, Kuzman D et al (2018) Impact of buffer, protein concentration and sucrose addition on the aggregation and particle formation during freezing and thawing. Pharm Res.

  9. 9.

    Wang W, Nema S, Teagarden D (2010) Protein aggregation—pathways and influencing factors. Int J Pharm 390:89–99.

  10. 10.

    Somero GN (1995) Proteins and temperature. Annu Rev Physiol 57:43–68.

  11. 11.

    Liu L, Braun LJ, Wang W et al (2014) Freezing-induced perturbation of tertiary structure of a monoclonal antibody. J Pharm Sci 103:1979–1986.

  12. 12.

    Pikal MJ (2004) Mechanisms of protein stabilization during freeze-drying storage: the relative importance of thermodynamic stabilization and glassy state relaxation dynamics. In: Freeze drying/lyophilization of pharmaceutical and biological products, Chapt 8. pp 198–232

  13. 13.

    Privalov PL (1990) Cold denaturation of proteins. Crit Rev Biochem Mol Biol 25:281–306.

  14. 14.

    Her L-M, Deras M, Nail SL (1995) Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes. Pharm Res 12:768–772.

  15. 15.

    Heller MC, Carpenter JF, Randolph TW (1996) Effects of phase separating systems on lyophilized hemoglobin. J Pharm Sci 85:1358–1362.

  16. 16.

    Heller MC, Carpenter JF, Randolph TW (1997) Manipulation of lyophilization-induced phase separation: implications for pharmaceutical proteins. Biotechnol Prog 13:590–596.

  17. 17.

    Heller MC, Carpenter JF, Randolph TW (1999) Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. Biotechnol Bioeng 63:166–174.;2-H

  18. 18.

    Chang BS, Kendrick BS, Carpenter JF (1996) Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J Pharm Sci 85:1325–1330.

  19. 19.

    Miller MA, Rodrigues MA, Glass MA et al (2013) Frozen-state storage stability of a monoclonal antibody: aggregation is impacted by freezing rate and solute distribution. J Pharm Sci 102:1194–1208.

  20. 20.

    Maity H, Karkaria C, Davagnino J (2009) Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze–thawing of fibroblast growth factor 20. Int J Pharm 378:122–135.

  21. 21.

    Cao E, Chen Y, Cui Z, Foster PR (2003) Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. Biotechnol Bioeng 82:684–690.

  22. 22.

    Anchordoquy TJ, Carpenter JF (1996) Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch Biochem Biophys 332:231–238.

  23. 23.

    Pikal-Cleland KA, Rodríguez-Hornedo N, Amidon GL, Carpenter JF (2000) Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase. Arch Biochem Biophys 384:398–406.

  24. 24.

    Hsu CC, Nguyen HM, Yeung DA et al (1995) Surface denaturation at solid-void interface—a possible pathway by which opalescent particulates from during the storage of lypholized tissue-type plasminogen activator at high temperatures. Pharm Res 12:69–77.

  25. 25.

    Webb SD, Cleland JL, Carpenter JF, Randolph TW (2003) Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma. J Pharm Sci 92:715–729.

  26. 26.

    Fransen GJ, Salemink PJM, Crommelin DJA (1986) Critical parameters in freezing of liposomes. Int J Pharm 33:27–35.

  27. 27.

    Kolhe P, Amend E, Singh SK (2010) Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation. Biotechnol Prog 26:727–733.

  28. 28.

    Hernández-Jiménez J, Martínez-Ortega A, Salmerón-García A et al (2018) Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles. Elsevier B.V, Amsterdam

  29. 29.

    Rašković B, Popović M, Ostojić S et al (2015) Fourier transform infrared spectroscopy provides an evidence of papain denaturation and aggregation during cold storage. Spectrochim Acta Part A Mol Biomol Spectrosc 150:238–246.

  30. 30.

    Radmanovic N, Serno T, Joerg S, Germershaus O (2013) Understanding the freezing of biopharmaceuticals: first-principle modeling of the process and evaluation of its effect on product quality. J Pharm Sci 102:2495–2507.

  31. 31.

    Wöll AK, Schütz J, Zabel J, Hubbuch J (2019) Analysis of phase behavior and morphology during freeze−thaw applications of lysozyme. Int J Pharm 555:153–164.

  32. 32.

    Kröner F, Hubbuch J (2013) Systematic generation of buffer systems for pH gradient ion exchange chromatography and their application. J Chromatogr A 1285:78–87.

  33. 33.

    Column P-10 D (2007) PD-10 desalting column

  34. 34.

    Baumgartner K, Galm L, Nötzold J et al (2015) Determination of protein phase diagrams by microbatch experiments: exploring the influence of precipitants and pH. Int J Pharm 479:28–40.

  35. 35.

    Galm L, Morgenstern J, Hubbuch J (2015) Manipulation of lysozyme phase behavior by additives as function of conformational stability. Int J Pharm 494:370–380.

  36. 36.

    Vitkup D, Ringe D, Petsko GA, Karplus M (2000) Solvent mobility and the protein “glass” transition. Nat Struct Biol 7:34–38.

  37. 37.

    Kumar P, Yan Z, Xu L et al (2006) Glass transition in biomolecules and the liquid-liquid critical point of water. Phys Rev Lett 97:1–4.

  38. 38.

    Muschol M, Rosenberger F (1997) Liquid–liquid phase separation in supersaturated lysozyme solutions and associated precipitate formation/crystallization. J Chem Phys.

  39. 39.

    Singh SK, Nema S (2010) Freezing and thawing of protein solutions. In: Formulation and process development strategies for manufacturing biopharmaceuticals, pp 625–675.

  40. 40.

    Cocks FH, Brower WE (1974) Phase diagram relationships in cryobiology. Cryobiology 11:340–358.

  41. 41.

    Kerwin BA, Heller MC, Levin SH, Randolph TW (1998) Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at −20 ˚C of a recombinant hemoglobin. J Pharm Sci 87:1062–1068.

  42. 42.

    Jameel F, Pikal MJ (2010) Design of a formulation for freeze drying. In: Part III: development of a formulation for lyophilized dosage form, Chapt 18. pp 459–492

  43. 43.

    Desai KG, Pruett WA, Martin PJ et al (2017) Impact of manufacturing scale freeze-thaw conditions on a mAb solution. BioPharm Int 30:30–36

  44. 44.

    Chi EY, Krishnan S, Randolph TW, Carpenter JF (2003) Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res 20:1325–1336.

  45. 45.

    Asherie N (2004) Protein crystallization and phase diagrams. Methods 34:266–272.

  46. 46.

    Saridakis E, Chayen NE (2008) Towards a ‘ universal ’ nucleant for protein crystallization. Cell Press.

  47. 47.

    Ataka M, Tanaka S (1986) The growth of large single crystals. Biopolymers 67:337–350.

  48. 48.

    Rodrigues MA, Miller MA, Glass MA et al (2011) Effect of freezing rate and dendritic ice formation on concentration profiles of proteins frozen in cylindrical vessels. J Pharm Sci.

  49. 49.

    Ataka M (1993) Protein crystal growth: an approach based on phase diagram determination. Phase Transitions A Multinatl J 45:205–219.

  50. 50.

    Garcıa-Ruiz JM (2003) Nucleation of protein crystals. J Struct Biol 142:22–31.

  51. 51.

    Chayen NE (2004) Turning protein crystallisation from an art into a science. Curr Option Struct Biol 14:577–583.

  52. 52.

    McPherson A (2004) Introduction to protein crystallization. Methods 34:254–265.

  53. 53.

    Chernov AA (2003) Protein crystals and their growth. J Struct Biol 142:3–21.

  54. 54.

    Lin C, Zhang Y, Liu JJ, Wang XZ (2017) Study on nucleation kinetics of lysozyme crystallization. J Cryst Growth 469:59–64.

  55. 55.

    Körber C (1988) Phenomena at the advancing ice—liquid interface: solutes particles and biological cells. Q Rev Biophys 21:229–298.

  56. 56.

    Butler MF (2001) Instability formation and directional dendritic growth of ice studied by optical interferometry. Cryst Growth Des 1:213–223.

  57. 57.

    Brody HD (1966) Solute redistribution in dendritic solidification. Trans Metall Soc AIME 236:615–624

  58. 58.

    Butler MF (2002) Freeze concentration of solutes at the ice/solution interface studied by optical interferometry. Cryst Growth Des 2:541–548

  59. 59.

    Weiss WF IV, Young TM, Roberts CJ (2009) Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. Int J Drug Dev Res 98:1246–1277.

  60. 60.

    Zeelen JP (2007) Interpretation of crystallization drop results. Molecular Dimension Monograph Series©

Download references

Author information

Correspondence to Jürgen Hubbuch.

Ethics declarations

Conflict of interest

The authors report no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 489 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wöll, A.K., Desombre, M., Enghauser, L. et al. A phase diagram-based toolbox to assess the impact of freeze/thaw ramps on the phase behavior of proteins. Bioprocess Biosyst Eng 43, 179–192 (2020) doi:10.1007/s00449-019-02215-5

Download citation


  • Temperature ramps
  • Phase diagram
  • Stability index
  • Lysozyme